Notably, patient samples of the lower-risk MDS subtypes refractory anemia and refractory anemia with ring sideroblasts, in which anemia is the predominant clinical presentation, have significantly elevated levels of GDF11 and ACVR2B transcripts (Figure 1B). The gene discussed is GDF11; the disease is myelodysplastic syndrome.